journal article·2022-03Open access

Thermo-responsive nano-in-micro particles for MRI-guided chemotherapy

Ziwei Zhang, Yuexin Wang, Marwa M.I. Rizk, Ruizheng Liang, Connor J.R. Wells, Pratik Gurnani, Fenglei Zhou, Gemma-Louise Davies, Gareth R. Williams

Abstract

In this work, we develop nano-in-micro thermo-responsive microspheres as theranostic systems for anti-cancer hyperthermia. Firstly, layered double hydroxide (LDH) nanoparticles were synthesized and subsequently loaded with the chemotherapeutic agents methotrexate (MTX) or 5-fluorouracil (5FU). The drug-loaded LDH particles were then co-encapsulated with superparamagnetic iron oxide nanoparticles (SPIONs) into poly(acrylamide-co-acrylonitrile) microparticles via spray drying. The SPIONs are able to act as MRI contrast agents, thus resulting in potential theranostic formulations. Concave microparticles were observed by electron microscopy, and elemental mapping results suggest the LDH and SPION particles were homogeneously distributed inside the microparticles. In vitro dissolution tests showed that the drug was released over a prolonged period of time with the microspheres having distinct release curves at 37 and 43 °C. The relaxivity (r2) profiles were also found to be different over the temperature range 35 to 46 °C. Mathematical relationships between r2, release and temperature data were established, demonstrating that the microparticles have the potential for use in MRI-guided therapy. In vitro cell experiments revealed that the formulations permit synergistic hyperthermia-aided chemotherapy in cultured Caco-2 and A549 cells. Thus, the microparticles prepared in this work have potential as smart stimuli-responsive theranostics for hyperthermia-aided chemotherapy.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Hydrogels: synthesis, properties, applications · Layered Double Hydroxides Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (72)

Show source-provided references
1. Novel diagnostic techniques: genomic, proteomic and systems biology approaches
2. Introduction to metallic nanoparticles10.4103/0975-7406.72127 ↗
3. Theranostics: combining imaging and therapy10.1021/bc200151q ↗
4. Nanomaterials for theranostics: recent advances and future challenges10.1021/cr300213b ↗
5. Cancer-associated, stimuli-driven, turn on theranostics for multimodality imaging and therapy10.1002/adma.201606857 ↗
6. Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment10.1016/j.apsb.2020.07.023 ↗
7. A nanostrategy for efficient imaging-guided antitumor therapy through a stimuli-responsive branched polymeric prodrug10.1002/advs.201903243 ↗
8. Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics10.7150/thno.38069 ↗
9. Functionalization of magnetic nanoparticles with peptide dendrimers10.1039/c0jm02752a ↗
10. pH-responsive nanocomposite fibres allowing MRI monitoring of drug release10.1039/D0TB01033B ↗
11. Thermo- and pH-responsive polymers in drug delivery10.1016/j.addr.2006.09.020 ↗
12. Hyperthermia techniques for cancer treatment: a review
13. Simulation techniques in hyperthermia treatment planning10.3109/02656736.2013.790092 ↗
14. Temperature-controlled uptake and release in PNIPAM-modified porous silica nanoparticles10.1021/cm703363w ↗
15. PNIPAM gel-coated gold nanorods for targeted delivery responding to a near-infrared laser10.1021/bc800480k ↗
16. Swelling behavior of γ-irradiation cross-linked elastomeric polypentapeptide-based hydrogels10.1021/ma0015673 ↗
17. Smart polymers for the controlled delivery of drugs—a concise overview10.1016/j.apsb.2014.02.005 ↗
18. Multifunctional superparamagnetic iron oxide nanoparticles for combined chemotherapy and hyperthermia cancer treatment10.1039/C5NR02718G ↗
19. A nano-in-micro system for enhanced stem cell therapy of ischemic diseases10.1021/acscentsci.7b00213 ↗
20. Layered double hydroxides: a review
21. 2D nanostructured metal hydroxides with gene delivery and theranostic functions; a comprehensive review10.1002/tcr.201700091 ↗
22. 2D layered double hydroxide nanoparticles: recent progress toward preclinical/clinical nanomedicine10.1002/smtd.201900343 ↗
23. Layered double hydroxide nanostructures and nanocomposites for biomedical applications10.1039/C9TB01312A ↗
24. A novel chitosan-based nanomedicine for multi-drug resistant breast cancer therapy10.1016/j.cej.2019.02.201 ↗
25. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis
26. Methotrexate bioavailability
27. Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer10.1038/sj.bjc.6605052 ↗
28. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system10.1186/jbiol69 ↗
29. pH-sensitive ZnO/carboxymethyl cellulose/chitosan bio-nanocomposite beads for colon-specific release of 5-fluorouracil10.1016/j.ijbiomac.2019.01.140 ↗
30. Synthesis and release of 5-fluorouracil from poly (N-vinylpyrrolidinone) bearing 5-fluorouracil derivatives10.1016/S0168-3659(02)00048-2 ↗
31. Manganese-based layered double hydroxide nanoparticles as a T1-MRI contrast agent with ultrasensitive pH response and high relaxivity10.1002/adma.201700373 ↗
32. Dually responsive mesoporous silica nanoparticles regulated by upper critical solution temperature polymers for intracellular drug delivery10.1039/C7TB02429K ↗
33. SiO2-coated layered gadolinium hydroxides for simultaneous drug delivery and magnetic resonance imaging10.1016/j.jssc.2020.121291 ↗
34. Efficient drug delivery using SiO2-layered double hydroxide nanocomposites10.1016/j.jcis.2016.02.042 ↗
35. Mg–Al layered double hydroxide–methotrexate nanohybrid drug delivery system: evaluation of efficacy10.1016/j.msec.2013.01.047 ↗
36. Synthesis and properties of Mg2Al layered double hydroxides containing 5-fluorouracil10.1016/j.jssc.2004.11.005 ↗
37. 5-Fluorouracil intercalated iron oxide@ layered double hydroxide core-shell nano-composites with isotropic and anisotropic architectures for shape-selective drug delivery applications10.1016/j.msec.2015.06.001 ↗
38. Structural and thermal properties of spray-dried methotrexate-loaded biodegradable microparticles10.1007/s10973-012-2580-3 ↗
39. Spray drying formulation of amorphous solid dispersions10.1016/j.addr.2015.12.010 ↗
40. A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation10.3109/10837450.2015.1026605 ↗
41. A facile synthetic strategy for Mg–Al layered double hydroxide material as nanocarrier for methotrexate10.1016/j.ceramint.2011.08.014 ↗
42. Loading kinetics of 5-fluorouracil onto hydrotalcite and in vitro drug delivery10.1016/j.jtice.2015.06.040 ↗
43. The role of hyperthermia in the multidisciplinary treatment of malignant tumors10.1177/1534735419876345 ↗
44. The role of apoptosis in the response of cells and tumours to mild hyperthermia10.1080/09553009114550441 ↗
45. Temperature distribution in human skin and subdermal tissue10.1016/0022-5193(83)90365-X ↗
46. Effects of temperature steps on human skin physiology and thermal sensation response10.1016/j.buildenv.2011.05.021 ↗
47. Professional and non-professional phagocytes: an introduction10.1016/S0962-8924(00)88955-2 ↗
48. Mesoporous silica nanoparticles for intracellular controlled drug delivery10.1002/smll.200901789 ↗
49. Nanovehicular intracellular delivery systems10.1002/jps.21270 ↗
50. Electrospun organic-inorganic nanohybrids as sustained release drug delivery systems10.1039/C7TB01825H ↗
51. Layered double hydroxides as drug carriers and for controlled release of non-steroidal antiinflammatory drugs (NSAIDs): a review10.1016/j.jconrel.2013.03.034 ↗
52. Intercalation of drugs in layered double hydroxides and their controlled release: a review10.1016/j.clay.2013.12.002 ↗
53. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices10.1016/0168-3659(87)90035-6 ↗
54. Scaled particle theory for the coil–globule transition of an isolated polymer chain10.1021/ma400338d ↗
55. Mathematical comparison of dissolution profiles
56. Guidelines on dissolution profile comparison10.1177/009286150103500325 ↗
57. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial10.1016/S0140-6736(00)02059-6 ↗
58. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study10.1016/S1470-2045(10)70071-1 ↗
59. Effect of local hyperthermia on blood flow and microenvironment: a review
60. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition10.1073/pnas.1101053108 ↗
61. Weekly paclitaxel combined with local hyperthermia in the therapy of breast cancer locally recurrent after mastectomy—a pilot experience10.1159/000079093 ↗
62. Mild temperature hyperthermia and radiation therapy: role of tumour vascular thermotolerance and relevant physiological factors10.3109/02656730903453546 ↗
63. Heat shock proteins and virus replication: HSP70s as mediators of the antiviral effects of prostaglandins10.1007/BF01923459 ↗
64. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles
65. Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines
66. Combination therapy with cinnamaldehyde and hyperthermia induces apoptosis of a549 non-small cell lung carcinoma cells via regulation of reactive oxygen species and mitogen-activated protein kinase family10.3390/ijms21176229 ↗
67. Hyperthermia: role and risk factor for cancer treatment
68. Effects of γ radiation and hyperthermia on DNA repair synthesis and the level of NAD+ in cultured human mononuclear leukocytes10.2307/3576192 ↗
69. Hyperthermia-induced DNA repair deficiency suggests novel therapeutic anti-cancer strategies10.3109/02656736.2012.695427 ↗
70. Effects of combined treatment of chemotherapeutics and hyperthermia on survival and the regulation of heat shock proteins in Dunning R3327 prostate carcinoma cells10.1002/(SICI)1097-0045(19980215)34:3<195::AID-PROS7>3.0.CO;2-H ↗
71. Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia10.2147/IJN.S94384 ↗
72. Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies10.1016/j.semcancer.2016.03.004 ↗